- Home
- ANIP vs SBGI Comparison
ANIP vs SBGI Comparison
Compare ANIP & SBGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIP
- SBGI
- Stock Information
- Founded
- ANIP 2001
- SBGI 1986
- Country
- ANIP United States
- SBGI United States
- Employees
- ANIP N/A
- SBGI N/A
- Industry
- ANIP Biotechnology: Pharmaceutical Preparations
- SBGI Broadcasting
- Sector
- ANIP Health Care
- SBGI Industrials
- Exchange
- ANIP Nasdaq
- SBGI Nasdaq
- Market Cap
- ANIP 1.2B
- SBGI 997.6M
- IPO Year
- ANIP N/A
- SBGI 1995
- Fundamental
- Price
- ANIP $68.02
- SBGI $15.91
- Analyst Decision
- ANIP Strong Buy
- SBGI Buy
- Analyst Count
- ANIP 8
- SBGI 5
- Target Price
- ANIP $79.75
- SBGI $19.30
- AVG Volume (30 Days)
- ANIP 361.8K
- SBGI 474.1K
- Earning Date
- ANIP 05-09-2025
- SBGI 05-07-2025
- Dividend Yield
- ANIP N/A
- SBGI 6.35%
- EPS Growth
- ANIP N/A
- SBGI N/A
- EPS
- ANIP N/A
- SBGI 4.69
- Revenue
- ANIP $614,376,000.00
- SBGI $3,548,000,000.00
- Revenue This Year
- ANIP $27.62
- SBGI N/A
- Revenue Next Year
- ANIP $7.71
- SBGI $3.90
- P/E Ratio
- ANIP N/A
- SBGI $3.36
- Revenue Growth
- ANIP 26.20
- SBGI 13.21
- 52 Week Low
- ANIP $52.50
- SBGI $11.13
- 52 Week High
- ANIP $70.00
- SBGI $18.45
- Technical
- Relative Strength Index (RSI)
- ANIP 66.14
- SBGI 54.46
- Support Level
- ANIP $65.28
- SBGI $15.23
- Resistance Level
- ANIP $69.33
- SBGI $17.01
- Average True Range (ATR)
- ANIP 2.32
- SBGI 0.69
- MACD
- ANIP 0.29
- SBGI 0.00
- Stochastic Oscillator
- ANIP 83.54
- SBGI 55.90
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
About SBGI Sinclair Inc.
Sinclair Inc. is the owner-operator of the second largest portfolio of television stations in the United States, with 185 full power stations in 86 markets. Of the firm's roughly 600 channels, 150 are affiliated with the four national broadcasters—Fox, ABC, CBS, and NBC—with over 80 other channels aligned with The CW (Nexstar) and MyNetworkTV (Fox). Sinclair owns the Tennis Channel and stakes in Marquee Sports Network and YES Network, providing their content to pay-TV distributors.